Printer Friendly

Directed Acquires Breathalyzer-based Ignition Interlock Device Specialist Alcohol Detection Systems.

M2 EQUITYBITES-January 17, 2018-Directed Acquires Breathalyzer-based Ignition Interlock Device Specialist Alcohol Detection Systems


17 January 2018 - US-based automotive electronics company Directed has acquired breathalyzer-based ignition interlock device provider Alcohol Detection Systems, the company said.

ADS provides IIDs under its Determinator product line, which Directed will maintain moving forward.

Evolving state regulations that require IID devices in DUI and DWI remediation programs have propelled the growth of the IID market.

A growing body of evidence shows that IIDs have a positive effect on reducing the incidence of drunk driving.

ADS products are easy to install and use. During remediation programs, users have IIDs installed in their cars, and the devices ensure that the driver successfully passes a breathalyzer test before allowing the car to start. It is typical for IIDs to be recalibrated on a regular basis and then uninstalled upon programme completion.

Directed is a division of DEI Holdings, a portfolio company of Boston-based private equity firm Charlesbank Capital Partners, LLC. Charlesbank acquired DEI Holdings in 2011.

Directed is in automotive electronics, the largest North American designer and marketer of consumer-branded vehicle security and remote start systems, and a pioneer in the connected car space.

Its products connect more consumers to their vehicles than anyone else on the planet.

Directed markets its broad portfolio (sold under Viper, Clifford, Python, Autostart, Astrostart and other brands) through national retailers and specialty chains.

Alcohol Detection Systems, based in Baltimore, Maryland, has been providing ignition interlock devices since 2002.

An ignition interlock device is a breath alcohol analyzer connected to the ignition of a car. A vehicle equipped with an ignition interlock device can only be driven when the driver passes the unit's breath alcohol tests. ADS is authorised to market IIDs in over twenty states across the country.

Based in Boston and New York, Charlesbank Capital Partners is a middle-market private equity investment firm managing more than USD 5bn of capital.

((Comments on this story may be sent to

COPYRIGHT 2018 Normans Media Ltd.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2018 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:M2 EquityBites (EQB)
Date:Jan 17, 2018
Previous Article:Alaska Air Group reports 2017 operational results.
Next Article:Biotage Closes USD 17.9m Acquisition of Horizon Technology.

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters